Found 4 matching trials
A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
PHASE2This is a Phase II, multicenter, open-label study. Eligible subjects who ha...
Location
Peking University First Hospital
Phase β
’ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
PHASE3Evaluate the efficacy and safety of HSK39297 tablets in patients with prima...
Location
Huangshan City People's Hospital
Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
PHASE2Evaluate the efficacy and safety of HSK39297 tablets in patients with prima...
Location
Peking University First Hospital
Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
PHASE2A double-blind,placebo controlled,randomized Phase 2 study to evaluate the ...
Location
Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine